Literature DB >> 8827943

Body fat and sympathetic nerve activity.

U Scherrer1, R Owlya, M Lepori.   

Abstract

Obesity, a major health problem in industrialized societies, is associated with a high incidence of cardiovascular complications such as hypertension, ischemic heart disease and stroke. However, the underlying mechanism relating obesity and these cardiovascular events is not clear. In lean subjects even slight elevations in plasma insulin concentration exert marked effects on the cardiovascular system, and these effects are directly related to insulin (rather than to insulin-induced stimulation of intermediary metabolism). Moreover, insulin's vascular effects are mediated both by the sympathetic nervous system and the L-arginine nitric oxide pathway. Obesity is characterized by sustained sympathetic activation (possibly related to chronic hyperinsulinemia) and an impaired vasodilator responsiveness to insulin. Although, undoubtedly many factors contribute to the increased incidence of cardiovascular complications in overweight subjects, sympathetic activation could be one important mechanism and either trigger acute events or--possibly in conjunction with an impairment in insulin-induced vasodilation--contribute to sustained elevation of arterial pressure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8827943     DOI: 10.1007/bf00120490

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  49 in total

1.  A comparison of the metabolic and circulatory effects of epinephrine, nor-epinephrine and insulin hypoglycemia with observations on the influence of autonomic blocking agents.

Authors:  R J DISALVO; W L BLOOM; A A BRUST; R W FERGUSON; E B FERRIS
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

2.  Overweight; its prognostic significance in relation to hypertension and cardiovascular-renal diseases.

Authors:  R L LEVY; P D WHITE
Journal:  J Am Med Assoc       Date:  1946-07-20

3.  Stimulation of the sympathetic nervous system during sucrose feeding.

Authors:  J B Young; L Landsberg
Journal:  Nature       Date:  1977-10-13       Impact factor: 49.962

4.  Body fat and sympathetic nerve activity in healthy subjects.

Authors:  U Scherrer; D Randin; L Tappy; P Vollenweider; E Jéquier; P Nicod
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

Review 5.  Trophic effects of peripheral adrenergic nerves on vascular structure.

Authors:  R D Bevan
Journal:  Hypertension       Date:  1984 Nov-Dec       Impact factor: 10.190

6.  Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man.

Authors:  J W Rowe; J B Young; K L Minaker; A L Stevens; J Pallotta; L Landsberg
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

7.  Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines.

Authors:  C Liang; J U Doherty; R Faillace; K Maekawa; S Arnold; H Gavras; W B Hood
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

Review 8.  Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone.

Authors:  A D Baron
Journal:  Baillieres Clin Endocrinol Metab       Date:  1993-10

9.  Effects of weight reduction on cellular cation metabolism and vascular resistance.

Authors:  D B Jacobs; J R Sowers; A Hmeidan; T Niyogi; L Simpson; P R Standley
Journal:  Hypertension       Date:  1993-03       Impact factor: 10.190

Review 10.  Hyperinsulinemia or increased sympathetic drive as links for obesity and hypertension.

Authors:  M Modan; H Halkin
Journal:  Diabetes Care       Date:  1991-06       Impact factor: 19.112

View more
  4 in total

1.  Vascularisation in adipose depots surrounding immune-stimulated lymph nodes.

Authors:  H A Macqueen; V Waights; C M Pond
Journal:  J Anat       Date:  1999-01       Impact factor: 2.610

2.  Pancreatic beta-cell alpha2A adrenoceptor and phospholipid changes in hyperlipidemic rats.

Authors:  L Clément; K A Kim-Sohn; C Magnan; N Kassis; P Adnot; M Kergoat; F Assimacopoulos-Jeannet; L Pénicaud; F Hsu; J Turk; A Ktorza
Journal:  Lipids       Date:  2002-05       Impact factor: 1.880

3.  Lipid infusion lowers sympathetic nervous activity and leads to increased beta-cell responsiveness to glucose.

Authors:  C Magnan; S Collins; M F Berthault; N Kassis; M Vincent; M Gilbert; L Pénicaud; A Ktorza; F Assimacopoulos-Jeannet
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

Review 4.  Metabolic complications of obesity.

Authors:  S M Grundy
Journal:  Endocrine       Date:  2000-10       Impact factor: 3.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.